Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Titan's CeaVac and TriAb studied in combination with radiation therapy for NSCLC

April 17, 2001

Herceptin receives Japanese approval for treatment of metastatic breast cancer

April 5, 2001

FDA supports Vical's Allovectin-7 clinical development program

April 5, 2001

Clinical data reported for an optimized Theratope vaccine formulation

April 5, 2001

Renewed focus on oncology products at Transgene

April 5, 2001

MabCampath recommended for approval in the E.U.

April 4, 2001

Timing of M-Vax administration crucial for survival and immunological outcomes

April 3, 2001

AACR news: preliminary phase I/II results with Vaxid indicate good safety, immunogenicity

March 30, 2001

Tumor growth completely suppressed by natural biological response modifier

March 28, 2001

AACR news: ImClone designs novel protein-based melanoma vaccine

March 28, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...